Literature DB >> 28045879

Inhibition of Complement: Tackling of Both Innate and Adaptive Immune Responses to Dampen Rejection.

Sriram Ambadapadi1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28045879      PMCID： PMC7228587          DOI： 10.1097/TP.0000000000001624

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  10 in total

1.  Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy.

Authors:  Peng Zhu; Stefanie R Bailey; Biao Lei; Chrystal M Paulos; Carl Atkinson; Stephen Tomlinson
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

Review 2.  Complement and its role in innate and adaptive immune responses.

Authors:  Jason R Dunkelberger; Wen-Chao Song
Journal:  Cell Res       Date:  2009-12-15       Impact factor: 25.617

3.  Relative antigenicity of components of a vascularized limb allograft.

Authors:  W P Lee; M J Yaremchuk; Y C Pan; M A Randolph; C M Tan; A J Weiland
Journal:  Plast Reconstr Surg       Date:  1991-03       Impact factor: 4.730

4.  Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome.

Authors:  Carla Nester; Zoe Stewart; David Myers; Jennifer Jetton; Ramesh Nair; Alan Reed; Christie Thomas; Richard Smith; Patrick Brophy
Journal:  Clin J Am Soc Nephrol       Date:  2011-05-26       Impact factor: 8.237

5.  Successful Salvage Treatment of Resistant Acute Antibody-Mediated Kidney Transplant Rejection with Eculizumab.

Authors:  Saif A Khan; Dawood Al-Riyami; Yasser W Al-Mula Abed; Saja Mohammed; Marwa Al-Riyami; Nabil M Al-Lawati
Journal:  Sultan Qaboos Univ Med J       Date:  2016-08-19

6.  Cytomegalovirus and other infectious issues related to face transplantation: specific considerations, lessons learned, and future recommendations.

Authors:  Chad R Gordon; Robin K Avery; William Abouhassan; Maria Siemionow
Journal:  Plast Reconstr Surg       Date:  2011-04       Impact factor: 4.730

7.  Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection.

Authors:  Carl Atkinson; Hongbin Song; Bo Lu; Fei Qiao; Tara A Burns; V Michael Holers; George C Tsokos; Stephen Tomlinson
Journal:  J Clin Invest       Date:  2005-08-25       Impact factor: 14.808

8.  Procurement of total human face graft for allotransplantation: a preclinical study and the first clinical case.

Authors:  Jean-Paul Meningaud; Marc-David Benjoar; Mickael Hivelin; Oana Hermeziu; Gaoussou Toure; Laurent Lantieri
Journal:  Plast Reconstr Surg       Date:  2010-10       Impact factor: 4.730

9.  Complement-Mediated Enhancement of Monocyte Adhesion to Endothelial Cells by HLA Antibodies, and Blockade by a Specific Inhibitor of the Classical Complement Cascade, TNT003.

Authors:  Nicole M Valenzuela; Kimberly A Thomas; Arend Mulder; Graham C Parry; Sandip Panicker; Elaine F Reed
Journal:  Transplantation       Date:  2017-07       Impact factor: 4.939

Review 10.  Potential Roles for C1 Inhibitor in Transplantation.

Authors:  Mel Berger; William M Baldwin; Stanley C Jordan
Journal:  Transplantation       Date:  2016-07       Impact factor: 4.939
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.